Accu-Break Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Accu-Break Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010852
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, and easy dose adjustment solutions among others. Its technologies are used in application of single drug, fixed dose combination, split dose combination, controlled-release, and incompatible drugs in human and veterinary medicines. The company develops tablets that can be easily divided into exactly smaller doses. Accu-Break is headquartered in Hollywood, Florida, the US.

Accu-Break Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Accu-Break Pharma Raises US$1 Million In Venture Financing 10
Licensing Agreements 11
GT Biopharma Enters into Licensing Agreement with Accu-Break Pharma 11
Accu-Break Pharma Enters Into Licensing Agreement With Alembic Pharma To Develop Novel Pharma Products 12
Accu-Break Pharmaceuticals Inc – Key Competitors 13
Accu-Break Pharmaceuticals Inc – Key Employees 14
Accu-Break Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Accu-Break Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Accu-Break Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Accu-Break Pharma Raises US$1 Million In Venture Financing 10
GT Biopharma Enters into Licensing Agreement with Accu-Break Pharma 11
Accu-Break Pharma Enters Into Licensing Agreement With Alembic Pharma To Develop Novel Pharma Products 12
Accu-Break Pharmaceuticals Inc, Key Competitors 13
Accu-Break Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[Accu-Break Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • REC Silicon ASA (REC)-エネルギー分野:企業M&A・提携分析
    Summary REC Silicon ASA (REC Silicon), formerly Renewable Energy Corporation ASA, produces and supplies advanced silicon materials. It offers solar grade polysilicon, electronic grade polysilicon, and silicon gases. Its products find application in the solar and electronics industries in the product …
  • McAlister’s Corporation:企業の戦略・SWOT・財務情報
    McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report Summary McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • General Motors Co (GM):企業の財務・戦略的SWOT分析
    General Motors Co (GM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Discover Financial Services:戦略・SWOT・企業財務分析
    Discover Financial Services - Strategy, SWOT and Corporate Finance Report Summary Discover Financial Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • KINeSYS Inc.:企業の戦略・SWOT・財務情報
    KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report Summary KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Peako Ltd (PKO):企業の財務・戦略的SWOT分析
    Summary Peako Ltd (Peako), formerly Peak Oil & Gas Ltd, is a mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold, silver and copper metals. Its projects include East Kimberley Region and Paterson Province. Peako’s East Kimberley Regi …
  • White Mountains Insurance Group Ltd:企業のM&A・事業提携・投資動向
    White Mountains Insurance Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's White Mountains Insurance Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Toromont Industries Ltd:企業の戦略・SWOT・財務情報
    Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ecobank Transnational Inc:企業の戦略・SWOT・財務情報
    Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report Summary Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • H2O Retailing Corporation:企業の戦略・SWOT・財務情報
    H2O Retailing Corporation - Strategy, SWOT and Corporate Finance Report Summary H2O Retailing Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • AusNet Services Ltd (AST)-エネルギー分野:企業M&A・提携分析
    Summary AusNet Services Ltd (AusNet) is a diversified energy network business entity that transmits and distributes power. It owns and manages electricity transmission network in Victoria; and delivers electricity to various customer connection points in eastern Victoria including Melbourne’s outer …
  • H. Lee Moffitt Cancer Center & Research Institute Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such a …
  • Pro Mach, Inc.:戦略・SWOT・企業財務分析
    Pro Mach, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pro Mach, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Journey Energy Inc (JOY):企業の財務・戦略的SWOT分析
    Summary Journey Energy Inc (Journey Energy), a subsidiary of Maples Investments LP, is an oil and gas company that offers exploration, development and production oil and natural gas assets. The company provides horizontal and multi-frac drilling, and secondary recovery methods that helps in acquirin …
  • Arthur J. Gallagher & Co:企業の戦略・SWOT・財務情報
    Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report Summary Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Otsuka Medical Devices Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Otsuka Medical Devices Co Ltd (Otsuka Medical Devices), a subsidiary of Otsuka Holdings Co Ltd, is a medical device manufacturing company. The company concentrates on revolutionary diagnostic and treatment technologies that find solutions in treating drug-refractory patients and intractable …
  • Smith & Nephew plc:企業のM&A・事業提携・投資動向
    Smith & Nephew plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smith & Nephew plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Luna Innovations Inc (LUNA):企業の財務・戦略的SWOT分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • XERIS Pharmaceuticals Inc (XERS):医療機器:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆